Best Targeted Therapy Treatment Hospitals Worldwide

At Vinmec Da Nang, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2017, the JCI accredited hospital is located in Da Nang, Vietnam, and has 222 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

Vinmec Nha Trang aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 2017 in Nha Trang, Vietnam and has 150 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

Aster Medcity aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH, JCI accredited hospital was established in 2013 in Kochi, India and has 670 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

Pushpawati Singhania Research Institute aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH, NABL accredited hospital was established in 1996 in Delhi, India and has 201 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

At Thumbay University Hospital, Ajman, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI accredited facility has been functioning since 2002 and is located in Ajman, United Arab Emirates. The hospital has 350 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

Meliva Kardiolita Hospital, Kaunas aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 1998 in Kaunas, Lithuania and has 8 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

With advanced oncology infrastructure, Bukit Tinggi Medical Centre offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2016, the MSQH accredited hospital is located in Kuala Lumpur, Malaysia, and has 171 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

Rajagiri Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 2014 in Kochi, India and it has adequate bed capacity to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

Fortis Hiranandani Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The NABH accredited hospital was established in 2007 in Mumbai, India and has 149 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

At Fortis Hospital, Shalimar Bagh, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2010, the NABH accredited hospital is located in Delhi, India, and has 262 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

At Max Super Specialty Hospital, Shalimar Bagh, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2011, the NABH, NABL accredited hospital is located in Delhi, India, and has 402 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

At Amrita Hospital, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2022, the NABH accredited hospital is located in Faridabad, India, and has 2600 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

The state-of-the-art Targeted Therapy services offered by IRCCS Policlinico San Donato, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in milan, Italy. Founded in 1969, the SSN accredited hospital has 430 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

With advanced oncology infrastructure, IRCCS Ospedale Galeazzi- Sant’Ambrogio offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 1963, the SSN accredited hospital is located in milan, Italy, and has 560 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

The state-of-the-art Targeted Therapy services offered by Marengo Asia Hospitals, Faridabad, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Faridabad, India. Founded in 2007, the NABH, NABL accredited hospital has 325 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.